Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2019 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (121)	2/23/2019 2:48:01 AM
From: BulbaMan	Respond to of 280

Just noticed I somehow screwed up again on my Week’s Top 5 Gainers & Losers. The numbers are actually for the past two weeks. Hopefully, I’ll get it right in next week’s update. Peace & good health, Bulba

To: BulbaMan who wrote (121)	2/23/2019 12:05:54 PM
From: A.J. Mullen	Read Replies (1) \| Respond to of 280

Bulba! You came from nowhere to seize first-place in one bound! That's an inspiration for us also-rans which deserves to be trumpeted. You're too modest. Ashley

To: BulbaMan who wrote (121)	3/1/2019 9:19:24 PM
From: BulbaMan	1 Recommendation Recommended By rkrw Read Replies (1) \| Respond to of 280

3/1/2019 Contest update Biotech investors celebrated the 1st day of March and showed no concern for the impending ides, a triple witching day. After all, why worry about witch hunts when biotechs are getting buyout bids at big premiums. Here are the happy numbers. At Friday’s close, the Contest median was up 20.41% YTD (vs. 14.57% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 18.92% YTD (vs. 14.42% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 27.54% YTD (vs. 19.08% YTD a week ago) and the Nasdaq Composite Index (NCI) was up 14.47% YTD (vs. up 13.45% YTD a week ago). (My own Contest portfolio continues to defy my humble expectations and has taken on a life of its own. So, henceforth, I will refer to it as BULBA’s portfolio.) Contest leader BULBA’s portfolio extended its hot streak. Getting an extra boost from the week’s top performing stock, MGTA, it is now up 61.58% YTD. HOOD’s portfolio, up 48.54% YTD, held on to second place and SANCTU’s portfolio, up 47.40%, moved up to third place. (My Contest portfolio, by the way, holds both the top YTD gainer, IMDZ, and top YTD loser, CFRX.) At Friday's close, 37 of the 39 Contest portfolios were in the green, with 24 beating the NBI and 14 even beating the sizzling SPSIBI. The 167 Contest stock picks have an average YTD gain of 27.49% and a median YTD gain of 22.51%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Enjoy a relaxing weekend biotechies! Peace & good health, Bulba 3/1/19 Rank Name Profit/Loss 1 BULBA 61,581 2 HOOD 48,544 3 SANCTU 47,402 4 RKRW 45,304 5 JACKH 43,968 6 OHMS 42,763 7 TRONKA 35,421 8 GHMM 35,141 9 GENE 33,108 10 BIOADD 32,079 Week's Top 5 Gainers Symbol 2/22/19 3/1/19 Wk.%chg. MGTA 9.390 15.020 59.96% TGTX 4.770 7.210 51.15% PBYI 26.680 38.930 45.91% QURE 41.600 57.310 37.76% MGTX 12.760 16.650 30.49% Week's Worst 5 Losers Symbol 2/22/19 3/1/19 Wk.%chg. IMGN 5.730 2.510 -56.20% CRBP 8.580 6.300 -26.57% KPTI 5.070 4.180 -17.55% IMRN 8.085 7.030 -13.05% SYBX 9.660 8.420 -12.84%